An out-of-specification result for the particle size parameter was found due to an incorrect limit at a manufacturing process stage (IPC), constituting a quality defect in batch 4201475. Potential effects: altered drug release, risk of lack of efficacy or increased adverse effects.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use product from batch 4201475 (expiry 12.2024); patients should check the batch number on the packaging and, if they have this batch, return it to the pharmacy and consult a doctor if the medi...
In 2023 the marketing of all Egoropal 75 mg batches was suspended; after investigation batch 4201475 was withdrawn and banned from marketing, and subsequently the suspension decision for the remaining...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related